Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration

K. Kantarci, Z. Nedelska, Q. Chen, ML. Senjem, CG. Schwarz, JL. Gunter, SA. Przybelski, TG. Lesnick, WK. Kremers, JA. Fields, J. Graff-Radford, R. Savica, D. Jones, H. Botha, DS. Knopman, V. Lowe, NR. Graff-Radford, MM. Murray, DW. Dickson, RR....

. 2022 ; 4 (2) : fcac013. [pub] 20220207

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017602

Mild cognitive impairment with the core clinical features of dementia with Lewy bodies is recognized as a prodromal stage of dementia with Lewy bodies. Although grey matter atrophy has been demonstrated in prodromal dementia with Lewy bodies, longitudinal rates of atrophy during progression to probable dementia with Lewy bodies are unknown. We investigated the regional patterns of cross-sectional and longitudinal rates of grey matter atrophy in prodromal dementia with Lewy bodies, including those who progressed to probable dementia with Lewy bodies. Patients with mild cognitive impairment with at least one core clinical feature of dementia with Lewy bodies (mean age = 70.5; 95% male), who were enrolled in the Mayo Clinic Alzheimer's Disease Research Center and followed for at least two clinical evaluations and MRI examinations, were included (n = 56). A cognitively unimpaired control group (n = 112) was matched 2:1 to the patients with mild cognitive impairment by age and sex. Patients either remained stable (n = 28) or progressed to probable dementia with Lewy bodies (n = 28) during a similar follow-up period and pathologic confirmation was available in a subset of cases (n = 18). Cross-sectional and longitudinal rates of grey matter atrophy were assessed using voxel-based and atlas-based region of interest analyses. At baseline, prodromal dementia with Lewy bodies was characterized by atrophy in the nucleus basalis of Meynert both in those who remained stable and those who progressed to probable dementia with Lewy bodies (P < 0.05 false discovery rate corrected). Increase in longitudinal grey matter atrophy rates were widespread, with greatest rates of atrophy observed in the enthorhinal and parahippocampal cortices, temporoparietal association cortices, thalamus and the basal ganglia, in mild cognitive impairment patients who progressed to probable dementia with Lewy bodies at follow-up (P < 0.05 false discovery rate corrected). Rates of inferior temporal atrophy were associated with greater rates of worsening on the clinical dementia rating-sum of boxes. Seventeen of the 18 (94%) autopsied cases had Lewy body disease. Results show that atrophy in the nucleus basalis of Meynert is a feature of prodromal dementia with Lewy bodies regardless of proximity to progression to probable dementia with Lewy bodies. Longitudinally, grey matter atrophy progresses in regions with significant cholinergic innervation, in alignment with clinical disease progression, with widespread and accelerated rates of atrophy in patients who progress to probable dementia with Lewy bodies. Given the prominent neurodegeneration in the cholinergic system, patients with prodromal dementia with Lewy bodies may be candidates for cholinesterase inhibitor treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017602
003      
CZ-PrNML
005      
20220720100309.0
007      
ta
008      
220718s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/braincomms/fcac013 $2 doi
035    __
$a (PubMed)35415608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kantarci, Kejal $u Department of Radiology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000280012081
245    10
$a Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration / $c K. Kantarci, Z. Nedelska, Q. Chen, ML. Senjem, CG. Schwarz, JL. Gunter, SA. Przybelski, TG. Lesnick, WK. Kremers, JA. Fields, J. Graff-Radford, R. Savica, D. Jones, H. Botha, DS. Knopman, V. Lowe, NR. Graff-Radford, MM. Murray, DW. Dickson, RR. Reichard, CR. Jack, RC. Petersen, TJ. Ferman, BF. Boeve
520    9_
$a Mild cognitive impairment with the core clinical features of dementia with Lewy bodies is recognized as a prodromal stage of dementia with Lewy bodies. Although grey matter atrophy has been demonstrated in prodromal dementia with Lewy bodies, longitudinal rates of atrophy during progression to probable dementia with Lewy bodies are unknown. We investigated the regional patterns of cross-sectional and longitudinal rates of grey matter atrophy in prodromal dementia with Lewy bodies, including those who progressed to probable dementia with Lewy bodies. Patients with mild cognitive impairment with at least one core clinical feature of dementia with Lewy bodies (mean age = 70.5; 95% male), who were enrolled in the Mayo Clinic Alzheimer's Disease Research Center and followed for at least two clinical evaluations and MRI examinations, were included (n = 56). A cognitively unimpaired control group (n = 112) was matched 2:1 to the patients with mild cognitive impairment by age and sex. Patients either remained stable (n = 28) or progressed to probable dementia with Lewy bodies (n = 28) during a similar follow-up period and pathologic confirmation was available in a subset of cases (n = 18). Cross-sectional and longitudinal rates of grey matter atrophy were assessed using voxel-based and atlas-based region of interest analyses. At baseline, prodromal dementia with Lewy bodies was characterized by atrophy in the nucleus basalis of Meynert both in those who remained stable and those who progressed to probable dementia with Lewy bodies (P < 0.05 false discovery rate corrected). Increase in longitudinal grey matter atrophy rates were widespread, with greatest rates of atrophy observed in the enthorhinal and parahippocampal cortices, temporoparietal association cortices, thalamus and the basal ganglia, in mild cognitive impairment patients who progressed to probable dementia with Lewy bodies at follow-up (P < 0.05 false discovery rate corrected). Rates of inferior temporal atrophy were associated with greater rates of worsening on the clinical dementia rating-sum of boxes. Seventeen of the 18 (94%) autopsied cases had Lewy body disease. Results show that atrophy in the nucleus basalis of Meynert is a feature of prodromal dementia with Lewy bodies regardless of proximity to progression to probable dementia with Lewy bodies. Longitudinally, grey matter atrophy progresses in regions with significant cholinergic innervation, in alignment with clinical disease progression, with widespread and accelerated rates of atrophy in patients who progress to probable dementia with Lewy bodies. Given the prominent neurodegeneration in the cholinergic system, patients with prodromal dementia with Lewy bodies may be candidates for cholinesterase inhibitor treatment.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nedelska, Zuzana $u Department of Radiology, Mayo Clinic, Rochester, MN, USA $u Department of Neurology, Charles University, Prague, Czech Republic
700    1_
$a Chen, Qin $u Department of Radiology, Mayo Clinic, Rochester, MN, USA $u Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China
700    1_
$a Senjem, Matthew L $u Department of Radiology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Schwarz, Christopher G $u Department of Radiology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Gunter, Jeffrey L $u Department of Radiology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Przybelski, Scott A $u Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
700    1_
$a Lesnick, Timothy G $u Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
700    1_
$a Kremers, Walter K $u Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
700    1_
$a Fields, Julie A $u Department of Psychology and Psychiatry, Mayo Clinic, Rochester, MN, USA
700    1_
$a Graff-Radford, Jonathan $u Department of Neurology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000327700691
700    1_
$a Savica, Rodolfo $u Department of Neurology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Jones, David $u Department of Neurology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Botha, Hugo $u Department of Neurology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/000000034390685X
700    1_
$a Knopman, David S $u Department of Neurology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Lowe, Val $u Department of Radiology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Graff-Radford, Neill R $u Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
700    1_
$a Murray, Melissa M $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Dickson, Dennis W $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000171897917
700    1_
$a Reichard, R Ross $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA
700    1_
$a Jack, Clifford R $u Department of Radiology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/000000017916622X
700    1_
$a Petersen, Ronald C $u Department of Neurology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Ferman, Tanis J $u Department of Psychology and Psychiatry, Mayo Clinic, Jacksonville, FL, USA
700    1_
$a Boeve, Bradley F $u Department of Neurology, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000241538187
773    0_
$w MED00205536 $t Brain communications $x 2632-1297 $g Roč. 4, č. 2 (2022), s. fcac013
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35415608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100304 $b ABA008
999    __
$a ind $b bmc $g 1816671 $s 1168844
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 4 $c 2 $d fcac013 $e 20220207 $i 2632-1297 $m Brain communications $n Brain Commun $x MED00205536
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace